|
Anitua, E., Andía, I., Sanchez, M., Azofra, J., del Mar Zalduendo, M.,
de la Fuente, M., Nurden, P. and Nurden, AT. (2005) Autologous preparations
rich in growth factors promote proliferation and induce VEGF and HGF production
by human tendon cells in culture. Journal of Orthopaedic Research
223(2), 281-286.
Arnoczky, S.P., Anderson, L., Fanelli, G., Ho, S., Mishra, A. and Scgalione,
N. (2009) The role of platelet-rich plasma in connective tissue repair.
Orthopaedics Today 226, 29.
Baltzer, A.W., Moser, C., Jansen, S.A. and Krauspe, R. (2009) Autologous
conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis.
Osteoarthritis and Cartilage 117, 152-160.
Banfi, G., Corsi, M.M. and Volpi, P. (2006) Could platelet rich plasma
have effects on systemic circulating growth factors and cytokine release
in orthopaedic applications? British Journal of Sports Medicine
440, 816.
Brabant, G., von zur Mühlen, A., Wüster, C., Ranke, M.B., Kratzsch, J.,
Kiess, W., Ketelslegers, J.M., Wilhelmsen, L., Hulthén, L., Saller, B.,
Mattsson, A., Wilde, J., Schemer, R. and Kann, P. (2003) Serum insulin
like Growth Factor 1 Reference Values for an Automated Chemiluminescence
Immunoassay System: Results from a Multicenter Study. Hormone Research
660, 53-60.
Buhr, M. and Siekmann, W. (2009) Intra-articular Injection of Platelet
Rich Plasma for cartilage repair. Orthopädische Praxis 45(1),
10-16.
Castricini, R., Longo, U.G., De Benedetto, M., Panfoli, N., Pirani, P.,
Zini, R., Maffulli, N. and Denaro, V. (2011) Platelet-rich plasma augmentation
for arthroscopic rotator cuff repair: a randomized controlled trial. The
American Journal of Sports Medicine 339, 258-265.
Chen, B., Liu, S., Xu, W., Wang, X., Zhao, W. and Wu, J. (2009) IGF-1
and IGFBP-3 and the risk of lung cancer: A meta-analysis based on nested
case-control studies. Journal of Experimental & Clinical Cancer Research
228, 89.
Cohen, J. (1988) Statistical power analysis for the behavioral sciences.
2nd edition. Lawrence Erlbaum Associates.
Conway, K., Price, P., Harding, K.G. and Jiang, W.G. (2006) The molecular
and clinical impact of hepatocyte growth factor, its receptors, activators,
and inhibitors in wound healing. Wound Repair and Regeneration
114, 2-10.
Creaney, L. and Hamilton, B. (2008) Growth factor delivery methods in
the management of sports injuries: the state of play. British journal
of Sports Medicine 442, 314-320.
Engebretsen, L., Steffen, K., Alsousou, J., Anitua, E., Bachl, N., Devilee,
R., Everts, P., Hamilton, B., Huard, J., Jenoure, P., Kelberine, F., Kon,
E., Maffulli, N., Matheson, G., Mei-Dan, O., Menetrey, J., Philippon,
M., Randelli, P., Schamasch, P., Schwellnus, M., Vernec, A. and Verrall,
G. (2010) IOC consensus paper on the use of platelet-rich plasma in sports
medicine. British journal of Sports Medicine 444, 1072-1081.
Eppley, B.L., Woodell, J.E. and Higgins, J. (2004) Platelet quantification
and growth factor analysis from platelet-rich plasma: implications for
wound healing. Plastic and Reconstructive Surgery 1114(6),
1502-1508.
Faul, F., Erdfelder, E., Lang, A-G. and Buchner, A. (2007) G*Power 3:
A flexible statistical power analysis program for the social, behavioral,
and biomedical sciences. Behavior Research Methods 339,
175-191.
Foster, T.E., Puskas, B.L., Mandelbaum, B.R., Gerhardt, M.B. and Rodeo,
S.A. (2009) Platelet-rich plasma: from basic science to clinical applications.
TThe American Journal of Sports Medicine 337, 2259-2272.
Griffin, X.L., Smith, C.M. and Costa, M.L. (2009) The clinical use of
platelet rich plasma in the promotion of bone healing: A systematic review.
Injury 440, 158-162.
Grimberg, A. and Cohen, P. (2000) Role of insulin-like growth factors
and their binding proteins in growth control and carcinogenesis. Journal
of Cellular Physiology 1183, 1-9.
Grimberg, A. (2003) Mechanisms by which IGF-1 may promote cancer. Cancer
Biology & Therapy 22, 630-635.
Kasemkijwattana, C., Menetrey, J., Bosch, P., Somogyi, G., Moreland, MS.,
Fu, F.H., Buranapanitkit, B., Watkins, S.S. and Huard, J. (2000)
Use of growth factors to improve muscle healing after strain injury. Clinical
Orthopaedics and Related Research 3370, 272-285.
Lann, D. and LeRoith, D. (2008) The role of endocrine insulin-like growth
factor-1 and insulin in breast cancer. Journal of Mammary Gland Biology
and Neoplasia 113, 371-379.
LeRoith, D. and Roberts, C.T. (2003) The Insulin-like growth factor system
and cancer. Cancer Letters 1195, 127-137.
Lopez-Vidriero, E., Goulding, K.A., Simon, D.A., Sanchez, M. and Johnson,
D.H. (2010) The use of platelet-rich plasma in arthroscopy and sports
medicine: optimizing the healing environment. Arthroscopy 226,
269-278.
Marx, R.E. (2004) Platelet-rich plasma: evidence to support its use. J
Oral and Maxillofacial Surgery 662, 489-496.
Mishra, A. and Pavelko, T. (2006) Treatment of chronic elbow tendinosis
with buffered platetelet-rich plasma. The American Journal of Sports
Medicine 334, 1774-1778.
Philippou, A., Maridaki, M., Halapas, A. and Koutsilieris, M. (2007)
The role of insulin-like growth factor 1(IGF-1) in skeletal muscle physiology.
In Vivo 221, 45-54.
Ranly, D.M., Lohmann, C.H., Andreacchio, D., Boyan, BD. and Schwartz,
Z. (2007) Platelet rich plasma inhibits demineralized bone matrix-induced
bone formation in nude mice. The Journal of Bone And Joint Surgery.
American Volume 889, 139-146.
Renehan, A.G., Zwahlen, M., Minder, C., O'Dwyer, S.T., Shalet, S.M. and
Egger, M. (2004) Insulin-like growth factor (IGF)-1, IGF binding protein-3,
and cancer risk: systematic review and meta-regression analysis. Lancet
3363, 1346-1353.
Rowlands, M.A., Gunnell, D., Harris, R., Vatten, L.J., Holly, J.M. and
Martin, R.M. (2009) Circulating insulin-like growth factor peptides and
prostate cancer risk: a systematic review and meta-analysis. International
Journal of Cancer 1124, 2416-2429.
Sánchez, M., Anitua, E., Azofra, J., Andía, I., Padilla, S. and Mujika,
I. (2007) Comparison of surgically repaired Achilles tendon tears
using platelet-rich fibrin matrices. The American Journal of Sports
Medicine 335, 245-251.
Sanchez, M., Anitua, E., Cugat, R., Azofra, J., Guadilla, J., Seijas,
R. and Andia, I. (2009a) Nonunions treated with autologous preparation
rich in growth factors. Journal of Orthopaedic Trauma 223,
52-59.
Sánchez, M., Anitua, E., Orive, G., Mujika, I. and Andia, I. (2009b)
Platelet-rich therapies in the treatment of orthopaedic sport injuries.
Sports medicine 339, 345-354.
Saugy, M., Robinson, N., Saudan, C., Baume, N., Avois, L. and Mangin,
P. (2006) Human growth hormone doping in sport. British Journal of
Sports Medicine 440, 35-39.
Sonksen, P.H. (2001) Insulin, growth hormone and sport. The Journal
of endocrinology 1170, 13-25.
Stay, J.J., Terrell, T.R. and Armsey, T.D. (2004) Ergogenic aids: human
growth hormone. Current Sports Medicine Reports 33, 229-233.
Tentori, L. and Graziani, G. (2007) Doping with growth hormone/IGF-1,
anabolic steroids or erythropoietin: is there a risk? Pharmacological
Research 55, 359-369.
WADA. (2011) The 2011 Prohibited List World Anti-Doping Code. Available
from URL http://www.wada-ama.org/Documents/ World_Anti-Doping_Program/WADP-Prohibited-list/To_be_
effective/WADA_Prohibited_List_2011_EN.pdf
WADA. (2008) World Anti-Doping Agency. Available from URL: http://www.wada-ama.org
(accessed 2008 Mar 16).
Volpi, P., Quaglia, A., Schoenhuber, H., Melegati, G., Corsi, M.M., Banfi,
G. and de Girolamo, L. (2010) Growth factors in the management of sport-induced
tendinopathies: results after 24 months from treatment. A pilot study.
The Journal of Sports Medicine and Physical Fitness 50,
494-500.
Wright-Carpenter, T., Opolon, P., Appell, H.J., Meijer, H., Wehling, P.
and Mir, LM. (2004) Treatment of muscle injuries by local administration
of autologous conditioned serum: animal experiments using a muscle contusion
model. International Journal of Sports Medicine 225, 582-587.
Yokota, K., Ishida, O., Sunagawa, T., Suzuki, O., Nakamae, A. and Ochi,
M. (2008) Platelet-rich plasma accelerated surgical angiogenesis
in vascular implanted necrotic bone: an experimental study in rabbits.
Acta Orthopaedica 779, 106-110.
|